Development of mammary cancer in E2 treated ACI rats is dramatically inhibited by concurrent treatment with tamoxifen, indicating a requirement for one or more estrogen receptor mediated mechanisms in tumor development [17,18]. This evidence concerns the gene ESR1 and breast cancer.